First launched in April 2015 the Apple Watch recently celebrated its second birthday. A failed product like some publishing media predicted? Certainly not.
Apple has made fashion and design a key cornerstone of its existence, but regarding the Watch it seems not to be the main reason why they created this product.
The late Apple CEO Steve Jobs developed pancreatic cancer in 2004. He then spent a great deal of time with doctors and the healthcare system until his death in 2011. While that personal health journey had a great impact on Jobs personally, it turns out that it affected Apple’s top management as well.
According to Jony Ive, the Apple Watch project was first touted shortly after Steve Jobs passed away in 2011. Jobs and others took on the task of trying to bring some digital order to various aspects of the healthcare system, especially the connection between patients, their data, and their healthcare providers.
Today we hear about a further step in Apple’s engagement in the healthcare system, a task Jobs gave the company before he died. For certain people with diabetes, the biggest innovation may be a single app: Dexcom’s Share2, which displays glucose data on the watch.
The Apple Watch’s continuous glucose monitoring (CGM) app is a milestone and will make diabetes more mainstream – and show the tech community that people with diabetes are eager to embrace advances in diabetes technology.
Here’s how it works: A Dexcom sensor with a hair-thin wire is placed just under the skin. A transmitter clips to it and sends glucose data via Bluetooth to the Dexcom CGM receiver, which then passes the information to an iPhone. From there, the data is sent to the watch through the Share2 app.
And while Apple’s products define Jobs’ legacy, it may turn out that his and Apple’s greatest contribution may be to bring greater order to conditions of health.